Investing.com - Baxter (NYSE: BAX) reported fourth quarter EPS of $0.88, $0.06 worse than the analyst estimate of $0.94. Revenue for the quarter came in at $3.9B versus the consensus estimate of $3.77B.
Guidance
Baxter sees Q1 2023 EPS of $0.46-$0.50 versus the analyst consensus of $0.76.
Baxter sees FY 2023 EPS of $2.75-$2.95 versus the analyst consensus of $3.56.
Baxter's stock price closed at $45.68. It is down -16.76% in the last 3 months and down -47.94% in the last 12 months.
Baxter saw 1 positive EPS revisions and 4 negative EPS revisions in the last 90 days. See Baxter's stock price’s past reactions to earnings here.
According to InvestingPro, Baxter's Financial Health score is "fair performance".
Check out Baxter's recent earnings performance, and Baxter's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar